Bayer and Curadev sign research collaboration and license agreement for STING antagonists Medical Dialogues Bureau25 March 2020 5:45 AM GMTBerlin & New Delhi: Bayer and Curadev Pvt. Ltd., a drug discovery company based in India, has announced a research collaboration and license agreem...
Tecentriq-Avastin cocktail helps liver cancer patients live longer: Roche Medical Dialogues Bureau25 Nov 2019 3:30 AM GMTMedian overall survival for patients with unresectable hepatocellular carcinoma (HCC), or that which cannot be surgically removed, getting Tecentriq an...
Bayer Roundup suits increase to 42700 Medical Dialogues Bureau1 Nov 2019 3:30 AM GMTA court-appointed mediator between Bayer and US plaintiffs in August denied reports the company had offered an $8 billion settlement to get the cases o...
Bayer disagrees with German Government decision to ban Glyphosate from end of 2023 Medical Dialogues Bureau6 Sep 2019 3:30 AM GMT'Such a ban would ignore the overwhelming scientific assessments of competent authorities around the world that have determined for more than 40 years ...
Former JnJ executive Marianne De Backer to lead Bayer pharma division Medical Dialogues Bureau4 Sep 2019 4:00 AM GMTMarianne De Backer will take the role of Head of Business Development & Licensing at Bayer's pharmaceuticals division, joining from rival JnJ, wher...
Bayer sells Animal Health unit to US drug firm Elanco for USD 7.6 billion Medical Dialogues Bureau21 Aug 2019 3:30 AM GMTBayer said in a statement that the sale, aimed at sharpening the company's focus on life sciences, was expected to be concluded in mid-2020 pending ant...
Roche personalized cancer treatment Rozlytrek priced at Rs 12 lakh per month Medical Dialogues Bureau17 Aug 2019 3:45 AM GMTRozlytrek was approved by the U.S. Food and Drug Administration on Thursday to treat certain types of solid tumours, which show rare genetic anomalies ...
Bayer buys BlueRock in USD 600 million bet on stem cell therapies Medical Dialogues Bureau9 Aug 2019 3:30 AM GMTFRANKFURT: German drugmaker Bayer is paying up to $600 million for full control of cell therapy developer BlueRock Therapeutics, stepping up...
Bayer Rivaroxaban tablets win CDSCO Committee nod for waiver of local clinical trial; directed to carry Phase IV trial Medical Dialogues Bureau8 Aug 2019 11:58 AM GMTNew Delhi: The apex drug regulatory body, Central Drugs Standard Control Organisation's (CDSCO) Technical Committee has recommended for grant of...
Cancer Drug Patent Issues: Delhi HC junks Bayer plea to block Natco Pharma Regonat Farhat Nasim15 July 2019 9:22 AM GMTNew Delhi: The Delhi High Court recently junked the injunction petition filed by the German Drugmaker to restrain the Hyderabad-based Natco Pharma...
GSK offers concessions to address Pfizer deal concerns Farhat Nasim23 Jun 2019 3:29 AM GMTGSK announced the deal in December last year, a move which will put it ahead of rivals Johnson & Johnson, Bayer and Sanofi.BRUSSELS:...
GSK forms drug discovery alliance with University of California CRISPR researchers Medical Dialogues Bureau14 Jun 2019 6:54 AM GMTBritish drugmaker GSK said it has struck a research deal with the early pioneers of a prominent gene-editing technology at the University of...
